Bone Densitometer Market Report Scope & Overview:

The Bone Densitometer Market Size was valued at USD 314.1 million in 2023 and is expected to reach USD 453.5 million by 2031, and grow at a CAGR of 4.7% over the forecast period 2024-2031.

The growth of the bone densitometer market will be supported by an increasing elderly population worldwide, which is at high risk for developing some types of bone disorders. For example, according to the UN Department of Economic and Social Affairs' estimates, by 2050 there are expected to be nearly 1.50 billion people aged 65 years or older. In addition, the need for bone densitometry as a valuable tool for screening, diagnosis and management of osteoporosis and vitamin D deficiency is highlighted by an increase in the incidence of osteoporosis and vitamin D deficiency. Bone densitometers facilitate risk assessment, treatment planning and monitoring of these conditions in order to improve patient outcomes through accurate evaluation of bone health.

Bone-Densitometer-Market Revenue Analysis

Get more information on Bone Densitometer Market - Request Sample Report



  • Raise the number of elderly people

  • Rising Incidence Osteoporosis

Densitometers, for example osteomalacia, osteoarthritis and osteoporotic fractures, assist in the detection and diagnosis of osteoporosis, osteopenia and diseases which lead to bone loss. The bone density of the patient is measured by a bone densitometer, which will determine whether or not these diseases occur. As per the International Osteoporosis Foundation (IOF), osteoporosis results in over 8.91 million fractures worldwide each year, equating to an osteoporotic fracture happening every three seconds.


  • The cost of bone densitometers is much higher.

Dual-energy X-ray absorptiometry (DEXA) is a commonly used technique for assessing bone mineral density. However, one of the main reasons why DEXA scanners are not widely used in developing countries is their relatively high cost. The average price of these products is between 9,180 and 199,000 USD. These systems are not affordable for most small and medium sized hospitals with controlled budgets, and instead they prefer significantly lower conventional prices. This is likely to limit the use of detectors for conversion from traditional analogue systems into Digital Systems, which poses a significant problem on the market.


  • Opportunities for growth in the emerging markets

Major growth opportunities for players in the bone densitometers market are offered by developing countries, including India, China and Brazil. Some of the main factors expected to contribute to market growth in these countries during the forecast period are high target patient population, improved healthcare infrastructure and growing awareness about health care. Governments invest heavily in their health systems to respond to the increasing need for diagnosis and detection of bone deformities and associated diseases across these countries.


  • The reimbursement scenario which is not favourable

  • Lack of access to diagnostics

Most bone diseases, such as osteoporosis and osteopenia, are not diagnosed or treated despite their widespread occurrence. This is due to a lack of or minimal knowledge about these diseases in developing countries, as well as the absence of sufficient resources for their detection. Osteoporosis develops slowly and is usually diagnosed in people over 60 years (and above 40 years in menopausal women).

Impact of Russia-Ukraine War

The availability and distribution of medical equipment, for example bone densitometers, may be affected by the current conflict in Russia and Ukraine. There may be a disruption of the supply chain for production and transport, which could lead to delays in procurement or maintenance of these devices. Moreover, access to bone densitometers may be further complicated by financial instability and the allocation of resources according to different priorities in those regions.

The reimbursement rate for haemodialysis, including laboratory tests and the cost of all IV drugs, has not been interrupted or modified by Ukraine's National Health System since the start of the war. Although Fresenius Medical Care's (FME) proportion of kidney replacement therapy (KRT) patients undergoing dialysis in its NephroCare (NC) clinics is relatively small (3.8% and 2.0% of the entire haemodialysis and peritoneal dialysis population in Ukraine, respectively), a concise narrative outlining the managerial obstacles encountered by healthcare professionals at the NC clinics and the challenges faced by dialysis patients is a valuable testimony to the strain inflicted by this war on a vulnerable, high-risk population reliant on intricate dialysis technology.

Impact of Economic Slowdown

As governments and healthcare organisations face budget constraints, the economic slowdown usually leads to a reduction in health expenditure. Investments in medical equipment, including bone densitometers, can be reduced as a result of this funding decrease. Individuals may postpone essential medical procedures, such as bone density tests, due to financial constraints during economic slowdown. The market may be negatively affected by this decrease in demand for bone densitometry services, leading to lower sales and revenue of the manufacturer. Delayed equipment upgrades: To conserve financial resources, healthcare facilities may delay or cancel plans for upgrading or replacing existing bone densitometers. This may result in an ageing equipment pool, which may affect the accuracy and reliability of the bone density test results.

Market Segmentation

By Technology

  • Axial Bone Densitometry

  • Dual energy x-ray absorptiometry (DEXA)

  • Quantitative computed tomography (QCT)

  • Peripheral Bone Densitometry

  • Quantitative ultrasound (QUS)

  • Radiographic Absorptiometry (RA)

  • Other Peripheral Bone Densitometry instruments

In 2023, the axial bone densitometry segment accounted for the highest revenue of USD 161.2 million. Dual-energy X-ray absorptiometry (DEXA) stands out as the primary method for assessing bone density in the body. This device is often employed for both the Central and Peripheral Bone density scans because of its high precision, ease of use and safety in adults and children.

By Application

  • Osteoporosis and osteopenia diagnosis

  • Cystic fibrosis diagnosis

  • Chronic kidney diseases diagnosis

  • Body composition measurement diagnosis

  • Rheumatoid arthritis diagnosis

In 2023, the osteoporosis and osteopenia diagnosis segment held a largest market share of 39.5%. Common conditions are osteoporosis and osteopenia, particularly in older people. The need for accurate bone densitometry, to determine and monitor bone health is driven by the increased incidence of these conditions. In addition, bone densitometry plays an important role in assessing the risk of fractures linked to osteoporosis and osteopenia. Bone densitometry aids in assessing the probability of fractures in individuals by measuring bone mineral density (BMD) at particular sites like the hip and spine.


By End User

  • Hospitals & specialty clinics

  • Diagnostic & imaging centers

  • Other end users

In 2023, the hospital & specialty clinic segment represents a significant share of 57.9% global market for bone densitometer. Due to the higher preference of patients for hospital based treatment monitoring of diseases such as cystic fibrosis, chronic kidney disease, and osteoporosis, a majority of bone density scans are performed in hospitals, which is driving segment growth.


Need any customization research on Bone Densitometer Market - Enquiry Now

Regional Analysis:

North America has the largest market share in the bone densitometer market, which is driven by the demand for bone densitometers. Also, due to a well-established healthcare infrastructure and a high incidence of osteoporosis and related bone disorders, in addition, the region has an increasing elderly population that is more prone to bone health problems. In addition, North America's dominant position in the bone densitometer market is further supported by the presence of major players on the market, technological advances and favourable reimbursement policy.

The Asia Pacific region is expected to show faster growth over the forecast period. The demand for bone densitometers is driven by a large and ageing population, as well as increased awareness of the issue of bone health and osteoporosis. In addition, accessibility to diagnostic technologies is facilitated by increasing health care costs and improving healthcare infrastructure. In addition, easier access to diagnostic technologies is facilitated by increasing healthcare costs and the development of medical infrastructure. Increased use of bone densitometers is also a result of the increasing incidence of osteoporosis and related bone disorders in this region.


North America

  • US

  • Canada

  • Mexico


  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of the Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America


Some of the major key players are DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company, Osteometer MediTech Inc., Hologic Inc., Swissray International Inc., Medilink and Other Players.

Medonica Co. Ltd-Company Financial Analysis

Company Landscape Analysis

Recent Developments:

  • In February 2022, Aurora Spine collaborated with Echolight Medical, the maker of the radiation-free "EchoS portable densitometer," which is employed to evaluate the software platform's efficacy and the bone mineral density (BMD) in affected patients. The two undertakings have chosen to place their products on the Aurora DEXA Platform in order to market them to each other's customer and prospects. This partnership will help companies to accelerate their revenue growth.

  • In May 2022, Echolight introduced the first radiation free technology for a portable bone densitometer at Florida Orthopedic Society's annual scientific meeting, Radiofrequency Echographic Multi Spectrometry REMS), which can safely monitor key indicators of bone health with higher frequency testing than any other methods.

Bone Densitometer Market Report Scope:

Report Attributes Details
Market Size in 2023 US$ 314.1 million
Market Size by 2031 US$ 453.5 Billion
CAGR CAGR of 4.7% From 2024 to 2031
Base Year 2023
Forecast Period 2024-2031
Historical Data 2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Technology (Axial Bone Densitometry, Dual energy x-ray absorptiometry (DEXA), Quantitative computed tomography (QCT), Peripheral Bone Densitometry, Quantitative ultrasound (QUS), Radiographic Absorptiometry (RA))
• By Application (Osteoporosis and osteopenia diagnosis, Cystic fibrosis diagnosis, Chronic kidney diseases diagnosis, Body composition measurement diagnosis, Rheumatoid arthritis diagnosis)
• By End User (Hospitals & specialty clinics, Diagnostic & imaging centers)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company, Osteometer MediTech Inc., Hologic Inc., Swissray International Inc., Medilink.
Key Drivers • Osteoporosis is progressing at a rise
• Raise in the population of geriatrics
RESTRAINTS • Very expensive bone densitometry

Frequently Asked Questions

Ans: The Bone densitometer Market size was valued at US$ 314.1 billion in 2023

Ans. The Bone densitometer Market is to grow at a CAGR of 4.7% over the forecast period 2024-2031

Ans. Key drivers of the Bone densitometer Market is Raise in the population of geriatrics, and decline in kidney disease prevalence 

Ans. DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company are the key plyer of Bone densitometer Market. 

Ans.  Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, Fundamental Research.


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Impact Analysis

5.1 Impact of Russia-Ukraine Crisis

5.2 Impact of Economic Slowdown on Major Countries

5.2.1 Introduction

5.2.2 United States

5.2.3 Canada

5.2.4 Germany

5.2.5 France

5.2.6 UK

5.2.7 China

5.2.8 Japan

5.2.9 South Korea

5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8.  Pest Analysis

9. Bone Densitometer Market, By Technology

9.1 Introduction

9.2 Trend Analysis

9.3 Axial Bone Densitometry

9.4 Dual energy x-ray absorptiometry (DEXA)

9.5 Quantitative computed tomography (QCT)

9.6 Peripheral Bone Densitometry

9.7 Quantitative ultrasound (QUS)

9.8 Radiographic Absorptiometry (RA)

9.9 Other Peripheral Bone Densitometry instruments

10. Bone Densitometer Market, By Application

10.1 Introduction

10.2 Trend Analysis

10.3 Osteoporosis and osteopenia diagnosis

10.4 Cystic fibrosis diagnosis

10.5 Chronic kidney diseases diagnosis

10.6 Body composition measurement diagnosis

10.7 Rheumatoid arthritis diagnosis

11. Bone Densitometer Market, By End-user

11.1 Introduction

11.2 Trend Analysis

11.3 Hospitals & specialty clinics

11.4 Diagnostic & imaging centers

11.5 Other end users

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2 Canada

12.2.3 Mexico

12.3 Europe

12.3.1 Eastern Europe Poland Romania Hungary Turkey Rest of Eastern Europe

12.3.2 Western Europe Germany France UK Italy Spain Netherlands Switzerland Austria Rest of Western Europe

12.4 Asia-Pacific

12.4.1 China

12.4.2 India

12.4.3 Japan

12.4.4 South Korea

12.4.5 Vietnam

12.4.6 Singapore

12.4.7 Australia

12.4.8 Rest of Asia Pacific

12.5 The Middle East & Africa

12.5.1 Middle East UAE Egypt Saudi Arabia Qatar Rest of the Middle East

11.5.2 Africa Nigeria South Africa Rest of Africa

12.6 Latin America

12.6.1 Brazil

12.6.2 Argentina

12.6.3 Colombia

12.6.4 Rest of Latin America

13. Company Profiles

13.1 DMS Imaging

13.1.1 Company Overview

13.1.2 Financial

13.1.3 Products/ Services Offered

13.1.4 SWOT Analysis

13.1.5 The SNS View

13.2 BeamMed Ltd.

13.2.1 Company Overview

13.2.2 Financial

13.2.3 Products/ Services Offered

13.2.4 SWOT Analysis

13.2.5 The SNS View

13.3 Ecolight S.P.A.

13.3.1 Company Overview

13.3.2 Financial

13.3.3 Products/ Services Offered

13.3.4 SWOT Analysis

13.3.5 The SNS View

13.4 Demetech AB.

13.4.1 Company Overview

13.4.2 Financial

13.4.3 Products/ Services Offered

13.4.4 SWOT Analysis

13.4.5 The SNS View

13.5 Medonica Co. Ltd

13.5.1 Company Overview

13.5.2 Financial

13.5.3 Products/ Services Offered

13.5.4 SWOT Analysis

13.5.5 The SNS View

13.6 General Electric Company

13.6.1 Company Overview

13.6.2 Financial

13.6.3 Products/ Services Offered

13.6.4 SWOT Analysis

13.6.5 The SNS View

13.7 Osteometer MediTech Inc.

13.7.1 Company Overview

13.7.2 Financial

13.7.3 Products/ Services Offered

13.7.4 SWOT Analysis

13.7.5 The SNS View

13.8 Hologic Inc.

13.8.1 Company Overview

13.8.2 Financial

13.8.3 Products/ Services Offered

13.8.4 SWOT Analysis

13.8.5 The SNS View

13.9 Swissray International Inc.

13.9.1 Company Overview

13.9.2 Financial

13.9.3 Products/ Services Offered

13.9.4 SWOT Analysis

13.9.5 The SNS View

13.10 Medilink.

13.10.1 Company Overview

13.10.2 Financial

13.10.3 Products/ Services Offered

13.10.4 SWOT Analysis

13.10.5 The SNS View

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share Analysis

14.3 Recent Developments

14.3.1 Industry News

14.3.2 Company News

14.3.3 Mergers & Acquisitions

15. Use Case and Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone